LinkedIn facebook twitter youtube
News archive
Recent news


Myeloma Patients Europe (MPE) will hold a webinar on myeloma and AL amyloidosis treatment updates on Wednesday 11 March 2020 from 18:30 – 19:30 CET.

The webinar will be given by Dr Inger Nijhof, Department of Hematology, VU University Medical Center, Amsterdam, Netherlands, who will give a 40-minute presentation on the latest developments in the treatment and care of myeloma and AL amyloidosis patients. The session will be followed by a 20-minute Q&A session.

This webinar is part of an educational programme planned to replace the Masterclass included in the MPE Annual General Meeting (AGM), which was cancelled due to the outbreak of the coronavirus infection.

The agenda for the Masterclass involved a wide-range of expert speakers on topics from myeloma and AL amyloidosis updates through to medicines regulation and health technology assessment. MPE is committed to delivering this programme of education through webinars, so please keep an eye out for further announcements in the coming weeks.

Registration is free of charge. Feel free to forward the registration link to colleagues and other patient advocates who might be interested in attending the webinar.

Should you be unable to attend the webinar, please feel free to send your questions in advance to info@mpeurope.org and we will make sure they reach our speaker.

A recording of the webinar will be available shortly after the session.

We look forward to your participation.



Recent news

» Daratumumab approved for first line treatment in Israel

» Join MPE's webinar on doctor and patients’ perspectives on myeloma CAR-T

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy